Estudio de las alteraciones genéticas en adenocarcinomas gástricos mediante aCGH y FISH en su contexto clínico-patológico

@inproceedings{Motta2014EstudioDL,
  title={Estudio de las alteraciones gen{\'e}ticas en adenocarcinomas g{\'a}stricos mediante aCGH y FISH en su contexto cl{\'i}nico-patol{\'o}gico},
  author={Otero Motta and Ana Pastora},
  year={2014}
}
[ES] Antecedentes Hasta ahora los estudios genomicos de alto rendimiento (aCGH) no se han correlacionado con las caracteristicas clinico-patologicas en series amplias de cancer gastrico ni se ha estudiado adecuadamente la heterogeneidad intratumoral. Los objetivos fueron: 1) determinar la incidencia de alteraciones cromosomicas mediante aCGH 2) correlacionarlas con el comportamiento clinico-patologico y evolucion 3) determinar las vias de evolucion clonal intratumorales. Material y metodos Se… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 649 REFERENCES

Gastric cancer

P. Correa, V. W. Chen
  • Cancer Surv 19-20,
  • 1994
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2016
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  • The New England journal of medicine
  • 2010
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Gastric cancer

Ajani, J.A
  • J Natl Compr Canc Netw
  • 2010
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2009
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL